# Kodiak AI, Inc.: financial statements, quarterly

KDK · Nasdaq · CIK 1853138 · [Technology](/sectors/technology.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/kdk.md) · [Financials](/companies/kdk/financials.md) · [Filings](/companies/kdk/filings.md) · [Insiders](/companies/kdk/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/kdk/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | not reported | not reported | not reported | not reported | [0.4](/filings/0001853138-25-000018.md) | [13.7 d](/filings/0001628280-26-016910.md) | [1.5](/filings/0001628280-26-032862.md) | [0.5](/filings/0001628280-26-054835.md) | [0.8](/filings/0001853138-25-000018.md) | [1.1 d](/filings/0001628280-26-016910.md) | [1.8](/filings/0001628280-26-032862.md) | [3.5](/filings/0001628280-26-054835.md) |
| Research and development | $m | not reported | not reported | not reported | not reported | [10.4](/filings/0001853138-25-000018.md) | [14.1 d](/filings/0001628280-26-016910.md) | [10.1](/filings/0001628280-26-032862.md) | [12.2](/filings/0001628280-26-054835.md) | [13.5](/filings/0001853138-25-000018.md) | [14.4 d](/filings/0001628280-26-016910.md) | [17.6](/filings/0001628280-26-032862.md) | [22.7](/filings/0001628280-26-054835.md) |
| Operating income | $m | [(0.4)](/filings/0001628280-24-047140.md) | [(53.2) d](/filings/0001628280-26-016910.md) | [(0.5)](/filings/0001628280-25-025871.md) | [(0.4)](/filings/0001628280-25-039912.md) | [(18.2)](/filings/0001853138-25-000018.md) | [(9.5)](/filings/0001628280-26-016910.md) | [(18.6)](/filings/0001628280-26-032862.md) | [(25.3)](/filings/0001628280-26-054835.md) | [(30.0)](/filings/0001853138-25-000018.md) | [(38.7)](/filings/0001628280-26-016910.md) | [(37.9)](/filings/0001628280-26-032862.md) | [(43.7)](/filings/0001628280-26-054835.md) |
| Interest expense | $m | not reported | not reported | not reported | not reported | [1.2](/filings/0001853138-25-000018.md) | [1.2 d](/filings/0001628280-26-016910.md) | [1.3](/filings/0001628280-26-032862.md) | [1.2](/filings/0001628280-26-054835.md) | [0.9](/filings/0001853138-25-000018.md) | [0.7 d](/filings/0001628280-26-016910.md) | [0.9](/filings/0001628280-26-032862.md) | [0.9](/filings/0001628280-26-054835.md) |
| Income tax | $m | not reported | not reported | not reported | not reported | [0.0](/filings/0001853138-25-000018.md) | [(0.0) d](/filings/0001628280-26-016910.md) | [0.0](/filings/0001628280-26-032862.md) | [0.0](/filings/0001628280-26-054835.md) | [0.0](/filings/0001853138-25-000018.md) | [(0.0) d](/filings/0001628280-26-016910.md) | [(0.0)](/filings/0001628280-26-032862.md) | [0.0](/filings/0001628280-26-054835.md) |
| Net income | $m | [6.4](/filings/0001628280-24-047140.md) | [(66.9) d](/filings/0001628280-26-016910.md) | [(18.0)](/filings/0001853138-25-000018.md) | [(18.0)](/filings/0001853138-25-000018.md) | [(19.1)](/filings/0001853138-25-000018.md) | [(14.4) d](/filings/0001628280-26-016910.md) | [(128)](/filings/0001628280-26-054835.md) | [(114)](/filings/0001628280-26-054835.md) | [(270)](/filings/0001853138-25-000018.md) | [(73.7) d](/filings/0001628280-26-016910.md) | [26.5](/filings/0001628280-26-054835.md) | [12.5](/filings/0001628280-26-054835.md) |
| Diluted EPS | $ per share | not reported | not reported | not reported | not reported | [(0.33)](/filings/0001853138-25-000018.md) | not reported | [(2.16)](/filings/0001628280-26-032862.md) | [(1.89)](/filings/0001628280-26-054835.md) | [(3.89)](/filings/0001853138-25-000018.md) | not reported | [0.10](/filings/0001628280-26-032862.md) | [(0.50)](/filings/0001628280-26-054835.md) |
| Basic EPS | $ per share | not reported | not reported | not reported | not reported | [(0.33)](/filings/0001853138-25-000018.md) | not reported | [(2.16)](/filings/0001628280-26-032862.md) | [(1.89)](/filings/0001628280-26-054835.md) | [(3.89)](/filings/0001853138-25-000018.md) | not reported | [0.12](/filings/0001628280-26-032862.md) | [(0.20)](/filings/0001628280-26-054835.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [2.3](/filings/0001628280-23-037137.md) | [27.8](/filings/0001628280-26-016910.md) | [1.6](/filings/0001628280-24-022660.md) | [1.4](/filings/0001628280-24-034757.md) | [33.2](/filings/0001853138-25-000018.md) | [16.7](/filings/0001628280-26-016910.md) | [17.7](/filings/0001628280-26-032862.md) | [20.2](/filings/0001628280-26-054835.md) | [146](/filings/0001853138-25-000018.md) | [50.8](/filings/0001628280-26-054835.md) | [65.0](/filings/0001628280-26-032862.md) | [46.8](/filings/0001628280-26-054835.md) |
| Current assets | $m | [2.9](/filings/0001628280-23-037137.md) | [2.4](/filings/0001628280-25-012406.md) | [2.1](/filings/0001628280-24-022660.md) | [1.8](/filings/0001628280-24-034757.md) | [1.4](/filings/0001628280-24-047140.md) | [20.2](/filings/0001628280-26-016910.md) | [0.7](/filings/0001628280-25-025871.md) | [2.8](/filings/0001628280-25-039912.md) | [152](/filings/0001853138-25-000018.md) | [126](/filings/0001628280-26-054835.md) | [95.3](/filings/0001628280-26-032862.md) | [157](/filings/0001628280-26-054835.md) |
| Total assets | $m | [519](/filings/0001628280-23-037137.md) | [525](/filings/0001628280-25-012406.md) | [532](/filings/0001628280-24-022660.md) | [539](/filings/0001628280-24-034757.md) | [546](/filings/0001628280-24-047140.md) | [35.6](/filings/0001628280-26-016910.md) | [557](/filings/0001628280-25-025871.md) | [561](/filings/0001628280-25-039912.md) | [178](/filings/0001853138-25-000018.md) | [159](/filings/0001628280-26-054835.md) | [131](/filings/0001628280-26-032862.md) | [194](/filings/0001628280-26-054835.md) |
| Current liabilities | $m | [0.3](/filings/0001628280-23-037137.md) | [0.3](/filings/0001628280-25-012406.md) | [0.4](/filings/0001628280-24-022660.md) | [0.5](/filings/0001628280-24-034757.md) | [0.6](/filings/0001628280-24-047140.md) | [31.2](/filings/0001628280-26-016910.md) | [3.1](/filings/0001628280-25-025871.md) | [12.2](/filings/0001628280-25-039912.md) | [34.7](/filings/0001853138-25-000018.md) | [26.7](/filings/0001628280-26-054835.md) | [25.9](/filings/0001628280-26-032862.md) | [28.3](/filings/0001628280-26-054835.md) |
| Total liabilities | $m | [22.8](/filings/0001628280-23-037137.md) | [22.8](/filings/0001628280-25-012406.md) | [22.9](/filings/0001628280-24-022660.md) | [23.0](/filings/0001628280-24-034757.md) | [23.1](/filings/0001628280-24-047140.md) | [116](/filings/0001628280-26-016910.md) | [25.6](/filings/0001628280-25-025871.md) | [27.0](/filings/0001628280-25-039912.md) | [174](/filings/0001853138-25-000018.md) | [219](/filings/0001628280-26-054835.md) | [154](/filings/0001628280-26-032862.md) | [160](/filings/0001628280-26-054835.md) |
| Long-term debt | $m | [5.0](/filings/0001628280-23-037137.md) | [5.0](/filings/0001628280-25-012406.md) | [5.0](/filings/0001628280-24-022660.md) | [5.0](/filings/0001628280-24-034757.md) | [5.0](/filings/0001628280-24-047140.md) | [17.6](/filings/0001628280-26-016910.md) | [5.0](/filings/0001628280-25-025871.md) | [5.0](/filings/0001628280-25-039912.md) | [11.1](/filings/0001853138-25-000018.md) | [29.9](/filings/0001628280-26-054835.md) | [29.8](/filings/0001628280-26-032862.md) | [29.5](/filings/0001628280-26-054835.md) |
| Current portion of debt | $m | not reported | not reported | not reported | not reported | not reported | [16.8](/filings/0001853138-25-000018.md) | not reported | not reported | [22.1](/filings/0001853138-25-000018.md) | [11.9](/filings/0001628280-26-016910.md) | [12.3](/filings/0001628280-26-032862.md) | [12.7](/filings/0001628280-26-054835.md) |
| Shareholders' equity | $m | [(19.8)](/filings/0001628280-24-047140.md) | [(187)](/filings/0001628280-26-016910.md) | [(204)](/filings/0001853138-25-000018.md) | [(221)](/filings/0001853138-25-000018.md) | [(238)](/filings/0001853138-25-000018.md) | [(251)](/filings/0001628280-26-054835.md) | [(377)](/filings/0001628280-26-054835.md) | [(487)](/filings/0001628280-26-054835.md) | [(220)](/filings/0001853138-25-000018.md) | [(283)](/filings/0001628280-26-054835.md) | [(246)](/filings/0001628280-26-054835.md) | [(189)](/filings/0001628280-26-054835.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(0.3) d](/filings/0001628280-24-047140.md) | [(42.8) d](/filings/0001628280-26-016910.md) | [(0.3)](/filings/0001628280-25-025871.md) | [(0.2) d](/filings/0001628280-25-039912.md) | [(35.7) d](/filings/0001853138-25-000018.md) | [(14.7) d](/filings/0001628280-26-016910.md) | [(16.5)](/filings/0001628280-26-032862.md) | [(20.4) d](/filings/0001628280-26-054835.md) | [(33.4) d](/filings/0001853138-25-000018.md) | [(24.2) d](/filings/0001628280-26-016910.md) | [(29.5)](/filings/0001628280-26-032862.md) | [(34.1) d](/filings/0001628280-26-054835.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | [2.4 d](/filings/0001628280-26-016910.md) | [2.3](/filings/0001628280-26-032862.md) | [2.9 d](/filings/0001628280-26-054835.md) | [6.6 d](/filings/0001853138-25-000018.md) | [10.1 d](/filings/0001628280-26-016910.md) | [5.5](/filings/0001628280-26-032862.md) | [3.9 d](/filings/0001628280-26-054835.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment

## Shares

| Line item | Unit | period not labelled (2022-03-31) | Q1 FY2023 (2023-03-31) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [11.3](/filings/0001628280-23-020688.md) | [11.3](/filings/0001628280-23-020688.md) | [58.4](/filings/0001853138-25-000018.md) | [59.3](/filings/0001628280-26-032862.md) | [60.2](/filings/0001628280-26-054835.md) | [69.4](/filings/0001853138-25-000018.md) | [216](/filings/0001628280-26-032862.md) | [193](/filings/0001628280-26-054835.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 200,618,170 at 2026-07-31, from the cover of the [10-Q filed 2026-08-07](/filings/0001628280-26-054835.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:49 ET. No prices; not investment advice.